Breaking
Home
Bank
Economy
industry
Markets
Opinion
Post Top Ad
Post Top Ad
Home
industry
Granules India expects FDA nod for drug from Gagillapur facility by FY26
Granules India expects FDA nod for drug from Gagillapur facility by FY26
industry,
It had voluntarily paused production in September
Newer Post
Older Post
Home
Post Top Ad
Recent
Contact
Footer menu
Home
Advertise With Us
Terms And Conditions
Privacy Policy
Sitemap
Jobs
About Us!
Post Of the day
Popular Posts
India boosts LNG buying to meet fertiliser, power demand amid supply woes
The buying will help meet requirements from fertilizer producers, which use gas as a feedstock and are ramping up output ahead of the planti...
RBI exempts FCNR (B) deposits, ECB swaps from forex position limit
The RBI has launched concessional forex swap facilities for FCNR deposits and external commercial borrowings, while easing regulatory requir...
Contact Form
Name
Email
*
Message
*